In addition, the results revealed that the patients in the high-risk group were enriched in primary immune deficiency, cell cycle arrest in response, and doxorubicin resistance, and the low-risk group was related to stem-cell downregulated, TNF signaling (Figure 5D,E). The gene discussed is TNF; the disease is Immunodeficiency.